세계의 림프 부종 치료 시장 - 규모, 점유율, 성장 분석 : 치료 유형별, 환부별, 연령층별, 투여 경로별, 유통 채널별, 최종 사용자별, 지역별, 산업별 예측(2025-2032년)
Lymphedema Treatment Market Size, Share, Growth Analysis, By Treatment Type, By Type, By Affected Area, By Age Group, By Route Of Administration, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032
림프 부종 치료 시장 규모는 2023년에 8억 6,014만 달러로 평가되었고, 2024년 9억 4,185만 달러에서 2032년에는 19억 22만 달러로 성장해 예측 기간(2025-2032년) 중 CAGR는 9.5%로 나타날 전망입니다.
림프 부종 치료 시장은 유방암 이환율의 상승이나 암 생존자에 있어서의 림프 부종의 만연 등 여러 요인에 의해 큰 성장을 이루고 있습니다. 특히 유방암 치료를 받은 여성의 40%가 림프부종을 발병하고 있으며, 이는 치료 직후 나타나는 경우도 있고 수십년 후에 나타날 수도 있습니다. 이 질환은 주로 하지에 영향을 미치고 부인과 암 환자의 발병률이 높습니다. 효과적인 림프 부종 치료 솔루션에 대한 수요는 주요 시장 진출기업의 기술 발전과 제품 혁신에 의해 촉진되고 있습니다. 림프부종의 쇠약을 경험하는 환자, 특히 수술 후 환자가 많은 가운데, 최첨단 암 치료법의 지속적인 개발은 이 증상을 완화하고 시장 기회를 확대하는데 있어서 매우 중요합니다.
목차
소개
조사 방법
- 정보 조달
- 2차 데이터와 1차 데이터의 방법
- 시장 규모 예측
- 시장의 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter's Five Forces 분석
주요 시장 인사이트
- 중요성공요인
- 경쟁도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제지표
- 밸류체인 분석
- 가격 분석
- 사례 연구 분석
림프 부종 치료 시장 규모 : 치료 유형별 &CAGR(2025-2032년)
- 시장 개요
- 압박요법
- 수술
- 약 요법
- 레이저 치료
- 기타
림프부종 치료 시장 규모 : 유형별 &CAGR(2025-2032년)
- 시장 개요
- 이차성 림프 부종
- 원발성 림프 부종
림프 부종 치료 시장 규모 : 질환 부위별 &CAGR(2025-2032년)
림프부종 치료 시장 규모 : 연령층별 &CAGR(2025-2032년)
림프부종 치료 시장 규모 : 투여경로별 &CAGR(2025-2032년)
림프부종 치료 시장 규모 : 유통채널별 &CAGR(2025-2032년)
림프 부종 치료 시장 규모 : 최종 사용자별 &CAGR(2025-2032년)
- 시장 개요
- 병원
- 전문 클리닉
- 외래수술센터(ASC)
- 기타
림프 부종 치료 시장 규모 &CAGR(2025-2032년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카
- 기타 중동 및 아프리카
경쟁 정보
- 상위 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채용한 전략
- 시장의 최근 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업의 기업 프로파일
- 제품 포트폴리오 분석
- 부문별 점유율 분석
- 수익의 전년대비 비교(2022-2024)
주요 기업 프로파일
- Bio Compression Systems
- Tactile Medical
- Medi
- Lympha Press
- Sigvaris
- BSN Medical
- L&R USA Inc.
- Devon Medical Products
- 3M Health Care
- JOBST USA
- Thuasne
- Wright Therapy Products
- BioHorizons IPH, Inc.
- Haddenham Healthcare
- ArjoHuntleigh
- Paul Hartmann
- Bioventus
- Baxter International Inc.
- CircAid Medical Products, Inc.
- Essity Aktiebolag
결론과 권장사항
JHS
Lymphedema Treatment Market size was valued at USD 860.14 Million in 2023 and is poised to grow from USD 941.85 Million in 2024 to USD 1900.22 Million by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).
The lymphedema treatment market is experiencing significant growth, driven by several factors including the rising incidence of breast cancer and the prevalence of lymphedema among cancer survivors. Notably, 40% of women undergoing breast cancer treatment develop lymphedema, which can manifest soon after treatment or even decades later. The disorder primarily affects the lower extremities and has higher occurrences among gynecologic cancer patients. The demand for effective lymphedema treatment solutions is also fueled by advancements in technology and product innovation from major market players. With a substantial patient population experiencing lymphedema's debilitating effects, particularly post-surgery, ongoing development of cutting-edge cancer therapies is critical to mitigating this condition and expanding market opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Lymphedema Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Lymphedema Treatment Market Segmental Analysis
Global Lymphedema Treatment Market is segmented by treatment type, type, affected area, age group, route of administration, distribution channel, end user and region. Based on treatment type, the market is segmented intoCompression Therapy, surgery, drug therapy, laser therapy and others. Based on type, the market is segmented into secondary lymphedema and primary lymphedema. Based on affected area, the market is segmented into lower extremity, upper extremity and genitalia. Based on age group, the market is segmented into adult, geriatric and pediatric. Based on route of administration, the market is segmented into oral, injectable and topical. Based on distribution channel, the market is segmented into pharmacy stores, direct tender and others. Based on end user, the market is segmented into hospital, speciality clinics, ambulatory surgical centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Lymphedema Treatment Market
The lymphedema treatment market is expected to grow significantly due to the rising incidence of lymphedema and breast cancer. An increase in cancer cases presents vast opportunities for market expansion. Coupled with surging health expenditures and heightened investments in drug discovery and development, demand for healthcare facilities is on the rise. Furthermore, the anticipated emergence of innovative lymphedema treatment options is likely to drive market growth during the forecast period. Technological advancements in treatment methodologies will also contribute to this upward trend. Additionally, government initiatives and favorable reimbursement policies are set to support the market's expansion.
Restraints in the Lymphedema Treatment Market
The Lymphedema Treatment market faces notable restraints that may hinder its growth. Despite technological advancements in the field, there remains no definitive cure for lymphedema, which poses a significant challenge to market development. Furthermore, the considerable expenses associated with various procedures and treatment options are anticipated to deter potential patients and healthcare providers, ultimately affecting overall market expansion. The combination of the lack of a permanent solution and the financial burden of managing lymphedema underscores the need for continued research and innovation to address these limitations and improve patient access to effective treatments.
Market Trends of the Lymphedema Treatment Market
The lymphedema treatment market is poised for significant growth, driven by an increasing prevalence of the condition and expanding awareness among healthcare providers and patients. Innovative therapies and advanced technologies are emerging at a rapid pace, enhancing treatment efficacy and patient safety. Rising healthcare expenditures globally are further propelling market expansion, alongside ongoing advancements in healthcare innovation that focus on personalized treatment options. Additionally, pharmaceutical companies are introducing cutting-edge medical devices, which are not only improving treatment outcomes but also stimulating market dynamics on a global scale, thereby positioning the lymphedema treatment market for sustained growth in the coming years.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Case Study Analysis
Global Lymphedema Treatment Market Size by Treatment Type & CAGR (2025-2032)
- Market Overview
- Compression Therapy
- Surgery
- Drug Therapy
- Laser Therapy
- Others
Global Lymphedema Treatment Market Size by Type & CAGR (2025-2032)
- Market Overview
- Secondary Lymphedema
- Primary Lymphedema
Global Lymphedema Treatment Market Size by Affected Area & CAGR (2025-2032)
- Market Overview
- Lower Extremity
- Upper Extremity
- Genitalia
Global Lymphedema Treatment Market Size by Age Group & CAGR (2025-2032)
- Market Overview
- Adult
- Geriatric
- Pediatric
Global Lymphedema Treatment Market Size by Route Of Administration & CAGR (2025-2032)
- Market Overview
- Oral
- Injectable
- Topical
Global Lymphedema Treatment Market Size by Distribution Channel & CAGR (2025-2032)
- Market Overview
- Pharmacy Stores
- Direct Tender
- Others
Global Lymphedema Treatment Market Size by End User & CAGR (2025-2032)
- Market Overview
- Hospital
- Speciality Clinics
- Ambulatory Surgical Centers
- Others
Global Lymphedema Treatment Market Size & CAGR (2025-2032)
- North America (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- Europe (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Bio Compression Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tactile Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lympha Press
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sigvaris
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BSN Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- L&R USA Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Devon Medical Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3M Health Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JOBST USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thuasne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wright Therapy Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioHorizons IPH, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Haddenham Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ArjoHuntleigh
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Paul Hartmann
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioventus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CircAid Medical Products, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Essity Aktiebolag
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
